Stock Market

InvestorPlace published an article last December about the seven hottest biotech stocks to own in 2023 and beyond. One of the seven was the SPDR S&P Biotech ETF (NYSEARCA:XBI). XBI tracks the performance of the S&P Biotechnology Select Industry Index which represents the biotechnology sub-sector of the S&P Total Market Index. XBI currently has 133
0 Comments
In 2024, UBS expects disinflation and rising unemployment to impact economic output, prompting the Federal Open Market Committee to implement proactive rate cuts. The FEderal Open Market Committee designed the initial cut to prevent the nominal funds rate from becoming overly restrictive amid falling inflation, with subsequent cuts later in the year to counteract economic
0 Comments
Initially concentrated on defense and intelligence, Palantir Technologies (NYSE:PLTR) has broadened its clientele to the healthcare, energy, and finance sectors. Noteworthy profitability and advancements in AI analytics make PLTR stock an appealing choice for investors. Despite the cooling of ‘AI mania,’ Palantir Technologies continues to hold firm, with shares not far below their 52-week highs.
0 Comments
Alphabet (NASDAQ:GOOGL,NASDAQ:GOOG) stock continues to be affected by the U.S. Department of Justice civil suit filed back in January, alleging that the company engaged in monopolistic and anti-competitive actions in order to maintain its dominant position in search and digital advertising markets. The trial, which started in September, is still unfolding. However, in recent days,
0 Comments
Meta Platforms (NASDAQ:META) has a number of threats to contend with, including regulatory resistance from the European Data Protection Board. Yet, the biggest threat of all might come from a famous electric vehicle (EV) manufacturing mogul. Overall, I still like the growth prospects for META stock, but investors should consider Meta Platforms’ challenges. I must admit, Meta Platforms
0 Comments
Paypal (NASDAQ:PYPL) stock has had a rough go of it, but the company has a storied history. It gave Elon Musk his first big profit. Co-founder Peter Thiel became one of Silicon Valley’s leading political players. But that’s all ancient history. What PYPL stock has been doing lately is disappointing investors. Shares are down 22%
0 Comments
Apple (NASDAQ:AAPL) has surged 40% year-to-date, garnering a “buy” rating from analysts, with an updated target price of $187.73. In the consumer electronics sector, Apple has continued to remain the dominant force, providing continued innovation in key areas many view as the next profit centers for the company. The company has historically generated value through
0 Comments